Keyphrases
Epidermal Growth Factor Receptor
100%
Colon Cancer Cells
100%
Chemosensitivity
100%
Gefitinib
100%
Receptor Activity
100%
Sialylation
100%
ST6GAL1
100%
Cell Proliferation
18%
Colon Cancer
18%
Cell Growth
9%
Tumorigenesis
9%
Tumor Growth
9%
Cell Tumor
9%
Extracellular Signal-regulated Kinase
9%
Overexpression
9%
Adhesion
9%
Knockdown
9%
Malignancy
9%
Cancer Progression
9%
SW480
9%
Cytotoxic Effect
9%
Receptor Activation
9%
Carcinoma Cell Lines
9%
Anticancer Effect
9%
Downstream Signaling
9%
Colorectal Carcinoma Cells
9%
Radioresistance
9%
Chemoresistance
9%
Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor (EGFR-TKI)
9%
Growth in Vitro
9%
Galactosides
9%
Mutant Epidermal Growth Factor Receptor
9%
Colon Cancer Metastasis
9%
Wild-type Epidermal Growth Factor Receptor
9%
Colon Cancer Progression
9%
Sialyltransferase
9%
Enzyme Substrates
9%
Human Colon Cancer Cell Line
9%
Receptor Phosphorylation
9%
N-glycan
9%
Pharmacology, Toxicology and Pharmaceutical Science
Epidermal Growth Factor Receptor
100%
Receptor
100%
Gefitinib
100%
Colon Carcinoma
100%
Cancer Growth
22%
Tumor Growth
11%
Carcinogenesis
11%
Mitogen Activated Protein Kinase
11%
Glycan
11%
Metastasis
11%
Colorectal Carcinoma
11%
Drug Resistance
11%
Epidermal Growth Factor Receptor Kinase Inhibitor
11%
Sialyltransferase
11%
Galactoside
11%
Cytotoxicity
11%
Biochemistry, Genetics and Molecular Biology